Related Experiment Video
Updated: Aug 10, 2025
09:52
A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites
Published on: August 8, 2014
17.7K
Host-Derived Cytotoxic Agents in Chronic Inflammation and Disease Progression
1Medical Faculty, Institute of Medical Physics and Biophysics, Leipzig University, Härtelstr. 16-18, 04107 Leipzig, Germany.
International Journal of Molecular Sciences
|February 11, 2023
Summary
Host-derived cytotoxic agents drive inflammation. Protective mechanisms combat these agents, but their decline can cause chronic inflammation, cell destruction, and organ failure.
Area of Science:
- Immunology
- Cell Biology
- Pathophysiology
Background:
- Inflammation involves cytotoxic agents from immune and damaged cells.
- Resolution depends on antagonizing principles inactivating these agents.
- Decline in protection leads to chronic inflammation and cell damage.
Purpose of the Study:
- To review host-derived cytotoxic agents in inflammation.
- To discuss their corresponding protective principles.
- To highlight implications in disease pathogenesis.
Main Methods:
- Literature review of cytotoxic agents and protective mechanisms.
- Analysis of their roles in inflammatory processes.
- Synthesis of findings on disease pathogenesis.
Main Results:
- Identified major cytotoxic agent classes: reactive species, heme proteins, metal ions, proteases, peptides.
- Detailed their specific antagonizing principles.
- Linked impaired protection to chronic inflammation, cell destruction, and organ failure.
Conclusions:
- Host-derived cytotoxic agents are key drivers of inflammation.
- A balance between cytotoxic agents and protective principles is crucial for resolution.
- Dysregulation contributes significantly to inflammatory disease pathogenesis.
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
1.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
204
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
204
01:24T Cell Types and Functions
1.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.2K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
227
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
227
01:27Tumor Immunotherapy
615
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
615
01:28Inflammatory Response
3.7K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
3.7K